Theranexus Société Anonyme

ENXTPA:ALTHX Stock Report

Market Cap: €22.6m

Theranexus Société Anonyme Management

Management criteria checks 3/4

Theranexus Société Anonyme's CEO is Mathieu Charvériat, appointed in Mar 2013, has a tenure of 12.58 years. directly owns 3.88% of the company’s shares, worth €878.68K. The average tenure of the management team and the board of directors is 4.6 years and 6.9 years respectively.

Key information

Mathieu Charvériat

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure12.6yrs
CEO ownership3.9%
Management average tenure4.6yrs
Board average tenure6.9yrs

Recent management updates

Recent updates

Is Theranexus Société Anonyme (EPA:ALTHX) A Risky Investment?

Nov 24
Is Theranexus Société Anonyme (EPA:ALTHX) A Risky Investment?

Is Theranexus Société Anonyme (EPA:ALTHX) Weighed On By Its Debt Load?

May 17
Is Theranexus Société Anonyme (EPA:ALTHX) Weighed On By Its Debt Load?

Theranexus Société Anonyme's (EPA:ALTHX) Has Found A Path To Profitability

Feb 25
Theranexus Société Anonyme's (EPA:ALTHX) Has Found A Path To Profitability

CEO Compensation Analysis

How has Mathieu Charvériat's remuneration changed compared to Theranexus Société Anonyme's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2025n/an/a

-€3m

Mar 31 2025n/an/a

-€2m

Dec 31 2024n/an/a

-€2m

Sep 30 2024n/an/a

-€2m

Jun 30 2024n/an/a

-€3m

Mar 31 2024n/an/a

-€5m

Dec 31 2023€209k€200k

-€7m

Sep 30 2023n/an/a

-€7m

Jun 30 2023n/an/a

-€7m

Mar 31 2023n/an/a

-€7m

Dec 31 2022€252k€184k

-€7m

Sep 30 2022n/an/a

-€7m

Jun 30 2022n/an/a

-€8m

Mar 31 2022n/an/a

-€8m

Dec 31 2021€246k€184k

-€8m

Sep 30 2021n/an/a

-€7m

Jun 30 2021n/an/a

-€6m

Mar 31 2021n/an/a

-€5m

Dec 31 2020€253k€184k

-€5m

Sep 30 2020n/an/a

-€5m

Jun 30 2020n/an/a

-€6m

Mar 31 2020n/an/a

-€6m

Dec 31 2019€252k€184k

-€6m

Sep 30 2019n/an/a

-€6m

Jun 30 2019n/an/a

-€6m

Mar 31 2019n/an/a

-€6m

Dec 31 2018€240k€177k

-€5m

Compensation vs Market: Insufficient data to establish whether Mathieu's total compensation is reasonable compared to companies of similar size in the French market.

Compensation vs Earnings: Mathieu's compensation has been consistent with company performance over the past year.

CEO

Mathieu Charvériat

12.6yrs
Tenure
€208,804
Compensation

Mr. Mathieu Charvériat is Co-Founder of Theranexus Société Anonyme. He served as Chief Scientific Officer of Theranexus société anonyme until January 2023 and was responsible for research teams and scienti...

Leadership Team

NamePositionTenureCompensationOwnership
Mathieu Charvériat
Co-Founder12.6yrs€208.80k3.88%
€ 878.7k
Julien Veys
COO & Directorless than a year€153.23kno data
Christine Placet
Chief Financial Officer1.5yrsno datano data
Francoise Vincent-Larrode
Director of Human Resources7.8yrsno datano data
Marie Sebille
Chief Medical Officerno datano datano data
4.6yrs
Average Tenure

Experienced Management: ALTHX's management team is considered experienced (4.6 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Mathieu Charvériat
Co-Founder8.1yrs€208.80k3.88%
€ 878.7k
Julien Veys
COO & Director1.8yrs€153.23kno data
Jerome Martinez
Independent Director6.8yrs€15.00kno data
Rodolphe Besserve
Independent Director7yrs€15.00kno data
Franck Mouthon
Co-Founder & Directorno data€210.10k3.88%
€ 878.7k
Sebastien Descarpentries
Director8.1yrsno datano data
Eric Doulat
Independent Director4.8yrs€15.00kno data
Didier Cussac
Member of Scientific Councilno datano datano data
Jean-Antoine Girault
Member of Scientific Councilno datano datano data
Philippe Marin
Member of Scientific Councilno datano datano data
Paul Moser
Member of Scientific Councilno datano datano data
6.9yrs
Average Tenure

Experienced Board: ALTHX's board of directors are considered experienced (6.9 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/10/03 20:30
End of Day Share Price 2025/10/03 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Theranexus Société Anonyme is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Mohamed KaabouniPortzamparc BNP Paribas
Victor FlochStifel, formerly Bryan Garnier